CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The National Institutes of Health, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention this week announced funding of three separate human trials of the antiretroviral drug Viread to prevent HIV infections, The Wall Street Journal reports. The drug, approved for use as part of combination therapy to treat HIV infection, has been shown in early tests to prevent HIV infection when taken regularly as pre-exposure prophylaxis. The human trials will include studies of sexually active gay and bisexual men in San Francisco and Atlanta, sex workers in Cambodia, and HIV-negative volunteers in four African nations. The Gates Foundation has provided $6.5 million for the African study, the NIH is supporting the Cambodian trial with a $2.1 million grant, and the study of sexually active gay men is funded by a $3.5 million CDC grant. Some at-risk people are already taking the anti-HIV drug to help prevent HIV infection, the Journal reports, which draws both support and caution from physicians. "I believe in being ahead of the curve. But if we're wrong, the results could be devastating," said Howard Grossman, a New York AIDS specialist. Viread has such side effects as kidney and bone toxicity. But health experts also worry that those currently taking the anti-HIV medication to prevent infection could stop using condoms or increase their sexual risk-taking because they believe the medication will shield them from HIV infection, which has not yet been proven. Officials at Gilead Sciences, the maker of Viread, are optimistic that the trials will show that the medication lowers the chances of HIV infection and plan to examine ways to boost production of the drug to handle the "tremendous number of people who would require Viread," said company vice president of clinical research James Rooney.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Here Are Our 2024 Election Predictions. Will They Come True?
November 07 2023 1:46 PM
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
17 Celebs Who Are Out & Proud of Their Trans & Nonbinary Kids
November 30 2023 10:41 AM
Here Are the 15 Most LGBTQ-Friendly Cities in the U.S.
November 01 2023 5:09 PM
Which State Is the Queerest? These Are the States With the Most LGBTQ+ People
December 11 2023 10:00 AM
These 27 Senate Hearing Room Gay Sex Jokes Are Truly Exquisite
December 17 2023 3:33 PM
10 Cheeky and Homoerotic Photos From Bob Mizer's Nude Films
November 18 2023 10:05 PM
42 Flaming Hot Photos From 2024's Australian Firefighters Calendar
November 10 2023 6:08 PM
These Are the 5 States With the Smallest Percentage of LGBTQ+ People
December 13 2023 9:15 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
Watch Now: The Daily
Trending stories from our video partner Advocate Channel.
For more videos and shows go to advocatechannel.com.
Trending stories from our video partner Advocate Channel.
For more videos and shows go to advocatechannel.com.
Latest Stories
George Santos pulls out of New York congressional race
April 23 2024 7:04 PM
Biden will hammer Trump over abortion bans in Florida speech
April 23 2024 5:00 AM
Tristan Snell, who brought down Trump University, sees conviction in hush money case
April 22 2024 7:36 PM
Joe Biden admin marks Earth Day with major environmental initiatives
April 22 2024 4:18 PM
Texas Gov. Greg Abbott: 'We want to end' trans and gender nonconforming teachers
April 22 2024 4:13 PM
Nonbinary 17-year-old killed two years after being reported missing
April 22 2024 3:46 PM